New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs

A study identifies medication type, dosage, indication, and persistence as critical to long-term success, while a survey reveals cost and access issues driving risky behaviors.

Researchers from the Cleveland Clinic found that the type of GLP-1 drug, dosage, treatment indication, and medication persistence significantly impact long-term weight loss.
Patients taking semaglutide experienced more than double the weight loss compared to those on liraglutide, with higher doses and continuous access further enhancing results.
Medication prescribed for obesity led to greater weight loss than for type 2 diabetes, though the reasons remain unclear.
A survey by Ohio State University revealed that 25% of U.S. adults would consider using weight loss drugs without a prescription, primarily due to cost and insurance barriers.
Upcoming GLP-1 pills could revolutionize weight-loss treatment by offering a more convenient alternative to injections, though concerns about misuse and side effects persist.